Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| U01CA217851 | Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms | 2 | 2021 |
| DP1DA044371 | Deciphering the Relationship between Substance Use and Psychiatric Disorders from Whole Genome Sequencing Data | 1 | 2021 |
| F30AG060704 | Defining the Function of APOE in Autophagy and Neurodegeneration | 1 | 2021 |
| F30HL143906 | Reverse Engineering the Pulmonary Microvasculature | 1 | 2021 |
| F32AA028148 | Transcriptome-guided diagnosis and therapy for alcohol use disorder | 1 | 2021 |
| F32CA239356 | Overcoming stress driven suppression of the anti-tumor immune response in cancer - understanding the MDSC piece of the puzzle | 1 | 2021 |
| I01BX001669 | Chromatin Accessibility and Transcription Factor Networks in Rheumatoid Arthritis | 1 | 2021 |
| I01BX003625 | The role of ADAR2-associated RNA editing in pathogenesis of ALS | 1 | 2021 |
| I01CX001276 | PTSD-Related Accelerated Aging in DNA Methylation and Risk for Metabolic Syndrome | 1 | 2021 |
| I01CX001560 | Influence of T Cell Clonality on PD-1 Blockade in Non-Small Cell Lung Cancer | 1 | 2021 |
| K01DK109079 | Early Life Fatty Acid Exposures Dictate Obesity Predisposition | 1 | 2021 |
| K01HL130704 | Mechanisms and clinical relevance of hypercapnia-induced skeletal muscle atrophy in Chronic Obstructive Pulmonary Disease (COPD) | 1 | 2021 |
| K08CA218420 | Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer | 1 | 2021 |
| K08CA222630 | MUTANT AND WILD TYPE WT1 IN AML | 1 | 2021 |
| K08NS096117 | Next-Generation Diagnostics for Acute Encephalitis | 1 | 2021 |
| K22CA217997 | Defining the role of SWI/SNF chromatin remodeling complex mutations during melanoma progression | 1 | 2021 |
| K23HL138461 | Profiling the Lung Transcriptome for Precision Diagnosis of Respiratory Infections using Host/Pathogen Metagenomic Sequencing | 1 | 2021 |
| K24CA169004 | Genetics of mammographic density and breast cancer risk in Latinas | 1 | 2021 |
| K99AG065484 | Quantitating, Targeting, and Phenotyping In Vivo Cellular Senescence in Humans | 1 | 2021 |
| P01AG017586 | Frontotemporal Dementias: Genotypes and Phenotypes | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=34